Isodiol International Inc (ISOLF)

[lithiumjr]

Some German exposure just released, these things tend to come out before a big push or news.

Urgent: Strong numbers and giant leaps ahead

New 1,000% cannabis hot stock after 10.866% with Aurora cannabis

Our Cannabis Hot Stock Isodiol International Inc. (ISIN CA46500L1013 / WKN A2DTBH, ticker: 7C5, CSE: ISOL) is about to be launched in the second quarter of 2017. In the first quarter of 2017, $ 4.92 million and a profit of $ 897,000. The very likely quarterly figures for Q2 2017 will be reported in a few days. According to corporate investors, institutional investors are also prepared to put an eight-digit dollar amount into the acceleration of the already rapid growth of our cannabis hot stock. After gaining up to 1,475% of GW Pharmaceuticals cannabis shares, 10,866% of Aurora Cannabis and 53,700% of cannabis stocks from Canopy Growth, you can be right from the start when our new Cannabis Hot Stock Isodiol International (ISIN CA46500L1013 / WKN A2DTBH, ticker: 7C5, CSE: ISOL) to the stock market. From 10,000 EUR were up to 5.380.000 EUR. Do not miss this stock chance. Our new cannabis share recommendation Isodiol International Inc. is currently one of the fastest growing cannabis companies and has recently reported the breakeven. We expect breakthrough news and a course rally for our new Cannabis Hot Stock in the coming week.

From EUR 10,000 up to EUR 5.380.000 - Do not miss this stock chance

Up to 53,700% profit could be attributed to early investors with the cannabis shares of Canopy Growth Corp. do. The shares of the current number one of the cannabis industry exploded from a maximum of 53.700% from 0.025 CAD at the end of 2013 in only three years in the top at 13.45 CAD. From a stock purchase of 10,000 EUR a stately property of 5.380.000 EUR. Do not miss this unique stock chance. Currently, Canopy Growth is valued at EUR 1 billion - more than 93 times the current market value of our new cannabis Hot Stock Isodiol International Inc ..

Natural cannabis develops into the general purpose weapon of modern medicine
Unique and highly profitable business model

Our new Cannabis Hot Stock Isodiol International Inc. has developed a unique and highly profitable business model. The Cannabis Aktientip does not dispense with capital-intensive cannabis production. Instead, exclusive purchase contracts with cannabis producers are closed. Our Cannabis Hot Stock enhances the raw material of cannabis in the form of medical cannabis products and branded cannabis products for recreational use. In branded products the big profit is. Not the sugar-producing farmers, but the producers of sugary beverages, e.g. Coca Cola achieve the highest profit margins. In contrast to many other highly acclaimed cannabis companies, our Cannabis Hotstock Isodiol International Inc. already generates rapidly increasing sales and even profits.

The natural cannabinoid extract ISODIAL has already passed the clinical test phases successfully and is in marketing to pharmaceutical companies, chemical distributors, cosmetics manufacturers and the retail trade.

The medical cannabis product ISO Medical has also successfully passed the clinical tests and sales have already started. The target customers are pharmacies and health care providers.

5.9 million CAD sales and 850,000 CAD annual surplus
3.191% Sales growth - break even in the first financial year

Our Cannabis Aktientip of the Break Even already succeeded in the first operating year. Our Cannabis Hot Stock achieved a yearly profit of 850,478 CAD in the last year. Sales revenues exploded by 3.191% from $ 33,735 in May 2016 to $ 1,109 million in December 2016. In the first quarter of 2017, our new Cannabis Hot Stock generated revenues of $ 4.92 million and a profit of $ 897,000.

For the full year 2017, the top management already expects sales of CAD 23 million and an annual surplus of C $ 3.75 million.

The figures for the second quarter of 2017, which are expected in a few days, are expected to exceed the high expectations in business circles. A course rally for our Cannabis Hot Stock should be the logical result.

Rapid growth in sales from 5.9 million CAD in 2016 to 77 million CAD in 2020. Profit explosion from $ 0.85 million in 2016 to $ 20.95 million in 2020

The Proof of Concept has already succeeded in our Cannabis share recommendation Isodiol International Inc. However, the rapid growth has just begun. So be there when the next success train on the stock market. The management has already proved that it has developed a unique and highly profitable business model. The company expects a rapid growth in sales and earnings in the coming years. Revenue is expected to increase from $ 5.9 million in the past year 2016 to $ 77.4 million in 2020. The profit is expected to explode in the same period from $ 0.85 million to $ 20.95 million.

Completely underestimated in industry comparison - competitors rated up to 160 times higher

Our Cannabis Actientip Isodiol International Inc. is currently underestimated in the industry comparison. Thanks to its unique business model, our Cannabis Hot Stock is highly profitable, in contrast to many higher rated competitors. The Cannabis shares of GW Pharmaceuticals have risen by 1.475% from USD 8.51 to USD 134.02 within a few years. From a stock investment of 10,000 EUR was a small property of 157,485 EUR. GW Pharmaceuticals is currently valued at 1.72 billion euros on the stock exchange - more than 160 times as much as our new Cannabis Hot Stock Isodiol International Inc .. of only EUR 10.67 million.

Breaking news ahead - Strong quarterly figures and giant leaps ahead

We expect the groundbreaking news for our Cannabis Hot Stock Isodiol International Inc. in the coming weeks. The results for the second quarter of 2017, which are expected in a few days, are expected to significantly exceed the high expectations. In addition, our Cannabis Aktientip Unternehmenskreise is directly before the conclusion of further Riesendeals. We therefore expect a course rally for our Cannabis Hot Stock Isodiol International Inc.

Strong Outperformer - Price target 24M 1,50 EUR - 711% Kurschance

We therefore reaffirm our assessment of "Strong Outperformer" for our Cannabis Hot Stock Isodiol International Inc. The target price for 12 months is estimated at EUR 1.00 for our Cannabis stock recommendation. This corresponds to a stock chance of 441% for brave and risky investors with our Cannabis Aktientip. In the case of 24 months we consider a target price of 1.50 EUR for our Cannabis Hot Stock as realistic. This corresponds to a stock performance of 711% with our Cannabis share recommendation.